Skip to content

DMC Biotechnologies

3 viewers · 30d

Total raised

$4.8M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $4.8M
ROUNDS
1
INVESTORS
9
FOUNDED
N/A
HQ
Boulder, CO
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

DMC Biotechnologies, Inc. is a U.S.-based biomanufacturer dedicated to innovating the chemical industry by utilizing sustainable, bio-based production methods for specialty chemicals. By leveraging advanced techniques such as precision fermentation and synthetic biology, the company aims to manufacture high-quality chemical ingredients while minimizing environmental impact.

What sets it apart

DMC stands out through its Dynamic Metabolic Control™ technology, facilitating environmentally friendly production that significantly reduces carbon emissions compared to traditional chemical manufacturing.

Funding history

1 round
Equity+4Apr 8, 2025
Form D
+$4.8M$4.8M total

Latest SEC filings

via EDGAR · CIK 0001728411
Form D · Apr 8, 2025View on EDGAR

Products

1 tracked

Dynamic Metabolic Control™ Technology

Sustainable Chemicals

This technology platform enables efficient microbial fermentation for the production of specialty chemicals, providing reliable and sustainable bio-based alternatives to conventional chemicals.

  • Predictable fermentation processes
  • Robust and efficient production
  • Environmentally responsible alternatives